We are live on ! Find out more
CRM

Cramer Rosenthal McGlynn Portfolio holdings

AUM $1.36B
1-Year Est. Return 31.72%
This Fund
S&P 500
This Quarter Est. Return
-10.57%
1 Year Est. Return
+31.72%
3 Year Est. Return
+70.83%
5 Year Est. Return
+96.16%
10 Year Est. Return
+415.48%
AUM
$2.18B
AUM Growth
-$386M
Cap. Flow
-$83.9M
Cap. Flow %
-3.85%
Top 10 Hldgs %
25.97%
Holding
106
New
11
Increased
30
Reduced
57
Closed
7

Top Buys

Rank Stock Value
1
LMAT icon
LeMaitre Vascular
LMAT
+$20.6M
2
MTDR icon
Matador Resources
MTDR
+$16.8M
3
QDEL icon
QuidelOrtho
QDEL
+$16.2M
4
BURL icon
Burlington
BURL
+$15.7M
5
LW icon
Lamb Weston
LW
+$12.5M

Sector Composition

Rank Sector Weight
1 Industrials 22.59%
2 Financials 19.04%
3 Technology 10.65%
4 Consumer Discretionary 10.21%
5 Healthcare 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLW icon
101
Clearwater Paper
CLW
$339M
-361,238
Closed -$10.1M
CNI icon
102
Canadian National Railway
CNI
$76.9B
-8,023
Closed -$1.08M
LPRO
103
Open Lending Corp
LPRO
-429,251
Closed -$8.12M
MXL icon
104
MaxLinear
MXL
$6.06B
-166,160
Closed -$9.7M
ROG icon
105
Rogers Corp
ROG
$2.21B
-45,154
Closed -$12.3M
OCDX
106
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
-1,624,180
Closed -$30.3M

Similar funds

Cramer Rosenthal McGlynn's Q2 2022 Portfolio in Review

As of Q2 2022, Cramer Rosenthal McGlynn held 106 positions worth $2.18B, down 15% from $2.56B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cramer Rosenthal McGlynn withdrew a net $83.9M in Q2 2022, closing 7 positions and reducing 57 holdings. Its most notable exit was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Cramer Rosenthal McGlynn opened a new position in LeMaitre Vascular worth $21M.

  • Cramer Rosenthal McGlynn's largest Q2 2022 buy was LeMaitre Vascular: 461,403 shares worth $21M.
  • Cramer Rosenthal McGlynn added most to Lamb Weston in Q2 2022, an estimated $12.5M increase.
  • Cramer Rosenthal McGlynn's biggest Q2 2022 reduction was G-III Apparel Group, cutting an estimated $20.4M.
  • Cramer Rosenthal McGlynn fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $30.3M.
  • Cramer Rosenthal McGlynn's ten largest holdings make up 26% of its $2.18B portfolio in Q2 2022.
  • Cramer Rosenthal McGlynn opened 11 new positions and closed 7 in Q2 2022.
  • Cramer Rosenthal McGlynn's portfolio value fell 15% quarter-over-quarter to $2.18B.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2022, filed 12 Aug 2022.